A report was received on 23 jan 2024 from the nurse of a 54 year old female patient with a medical history including hypertension and end stage renal disease, who stated the patient experienced urticaria and facial angioedema approximately three minutes into the patient''s first hemodialysis treatment with the nxstage device on (b)(6) 2023.Treatment was terminated with oxygen administered, epinephrine times two doses (doses not specified) and diphenhydramine (benadryl) 50mg orally.The patient was transported to hospital, where she was observed and released the same day.Additional information was received on 25 jan 2024 from the nurse stating that following the event, the patient has recovered without sequalae and plans to continue treatments using a dialyzer from a different manufacturer.
|